Saptarsi Haldar, M.D.

Dr. Haldar is a scientific founder of Tenaya Therapeutics. He is currently vice president of research and head of cardiometabolic disorders at Amgen. He is also a visiting investigator at the Gladstone Institutes and professor of medicine at the University of California, San Francisco (UCSF). He received his B.S. from Cornell University and his M.D. from Johns Hopkins University School of Medicine. He trained in internal medicine at Johns Hopkins followed by a fellowship in cardiovascular disease at Brigham and Women’s Hospital, Harvard Medical School. Prior to joining Gladstone, he was on the faculty at Case Western Reserve University School of Medicine. Dr. Haldar is a physician-scientist who has made important discoveries in the areas of cardiac, skeletal muscle and metabolic biology. His laboratory seeks to gain a deep understanding of how cells in the cardiovascular system control gene expression and how these processes go awry in disease. He has a particular interest in discovering signaling effectors that are tractable pharmacologic targets for disease therapy. His work has elucidated therapeutically relevant insights for a broad range of conditions including heart failure, vasculopathy and muscular dystrophy. Dr. Haldar has been elected as a fellow of the American Heart Association. He is an active member of the American Society for Clinical Investigation and continues to practice general adult cardiology at UCSF.